Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Zurawski

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Multiple Sclerosis and Related Disorders|June 16, 2022
COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disordersSarah E Conway, Brian C Healy, Jonathan Zurawski, et al.
Scientific Reports|April 8, 2025
Novel serum biomarker associations with 7 Tesla MRI-defined cortical lesions, leptomeningeal enhancement, and deep gray matter volume in early multiple sclerosisAndrei Miclea, Jonathan Zurawski, Brian C Healy, et al.
Multiple Sclerosis and Related Disorders|May 16, 2022
Disease modifying therapy management of multiple sclerosis after stem cell therapies: A retrospective case seriesGiovanna S Manzano, Kathryn B Holroyd, Tamara Kaplan, et al.
Molecular Biology of the Cell|October 3, 2008
The scaffold protein POSH regulates axon outgrowthJennifer Taylor, Kwan-Ho Chung, Claudia Figueroa, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|March 19, 2025
Cladribine Is Associated With Stable Cortical Gray Matter Lesion Burden in Multiple Sclerosis: A 7T MRI StudyJonathan Zurawski, Shahamat Tauhid, Brian C Healy, et al.
Cell Reports. Medicine|April 4, 2025
Gut microbiota and metabolites are linked to disease progression in multiple sclerosisLuke A Schwerdtfeger, Federico Montini, Toby B Lanser, et al.
Neurology. Clinical Practice|January 15, 2025
A Real-World Prospective Multiple Sclerosis Pregnancy Registry in the United States: PREG-MSMaria K Houtchens, Maria Claudia Manieri, Tatenda Dawn Mahlanza, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2026
ODC1 restricts meningeal B cell age-associated-like phenotype and function in multiple sclerosis: A human and experimental studyJonathan Zurawski, Alara Tuncer, Martin R Profant, et al.
Multiple Sclerosis and Related Disorders|August 11, 2022
Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomesKathryn B Holroyd, Brian C Healy, Sarah Conway, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|August 16, 2023
Intersite brain MRI volumetric biases persist even in a harmonized multisubject study of multiple sclerosisKelly A Clark, Carly M O'Donnell, Mark A Elliott, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Multiple Sclerosis and Related Disorders|June 16, 2022
COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disordersSarah E Conway, Brian C Healy, Jonathan Zurawski, et al.
Scientific Reports|April 8, 2025
Novel serum biomarker associations with 7 Tesla MRI-defined cortical lesions, leptomeningeal enhancement, and deep gray matter volume in early multiple sclerosisAndrei Miclea, Jonathan Zurawski, Brian C Healy, et al.
Multiple Sclerosis and Related Disorders|May 16, 2022
Disease modifying therapy management of multiple sclerosis after stem cell therapies: A retrospective case seriesGiovanna S Manzano, Kathryn B Holroyd, Tamara Kaplan, et al.
Molecular Biology of the Cell|October 3, 2008
The scaffold protein POSH regulates axon outgrowthJennifer Taylor, Kwan-Ho Chung, Claudia Figueroa, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|March 19, 2025
Cladribine Is Associated With Stable Cortical Gray Matter Lesion Burden in Multiple Sclerosis: A 7T MRI StudyJonathan Zurawski, Shahamat Tauhid, Brian C Healy, et al.
Cell Reports. Medicine|April 4, 2025
Gut microbiota and metabolites are linked to disease progression in multiple sclerosisLuke A Schwerdtfeger, Federico Montini, Toby B Lanser, et al.
Neurology. Clinical Practice|January 15, 2025
A Real-World Prospective Multiple Sclerosis Pregnancy Registry in the United States: PREG-MSMaria K Houtchens, Maria Claudia Manieri, Tatenda Dawn Mahlanza, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2026
ODC1 restricts meningeal B cell age-associated-like phenotype and function in multiple sclerosis: A human and experimental studyJonathan Zurawski, Alara Tuncer, Martin R Profant, et al.
Multiple Sclerosis and Related Disorders|August 11, 2022
Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomesKathryn B Holroyd, Brian C Healy, Sarah Conway, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|August 16, 2023
Intersite brain MRI volumetric biases persist even in a harmonized multisubject study of multiple sclerosisKelly A Clark, Carly M O'Donnell, Mark A Elliott, et al.
Pageof 4